Creative Biolabs provides in vitro safety assessment services, utilizing high-content screening to evaluate hepatotoxicity, cardiotoxicity, and genotoxicity. We quantify cellular stress and membrane integrity to de-risk candidates before preclinical regulatory submissions.
Learn More →Small Molecule Safety Pharmacology Evaluation Services
Creative Biolabs transcends standard "check-box" compliance by providing deep physiological insights into off-target interactions and rare lethal risks. Our comprehensive reports correlate functional changes with structural data to navigate the pharmacology-pathology relationship. By leveraging specialized secondary pharmacology and immunotoxicity screening, we de-risk complex hybrid modalities and identify liabilities standard toxicology often misses. This data-driven approach ensures lead candidates are optimized for safety, providing a clear, robust path for successful regulatory submissions and first-in-human trials.
Background Featured Services Workflow Why Choose Us FAQs Customer Review Related Services Contact Us
Introduction to Small Molecule Safety Pharmacology
Small molecule safety pharmacology is a specialized scientific discipline designed to identify functional risks to vital organ systems, specifically the cardiovascular (CV), central nervous (CNS), and respiratory systems, that are not typically detected in standard toxicology studies. Unlike traditional toxicity testing, which evaluates structural tissue damage or mortality at high doses, safety pharmacology characterizes the relationship between drug exposure and acute functional changes within the therapeutic window. This field is essential for detecting rare but lethal risks, such as drug-induced arrhythmias or sudden respiratory depression, which can derail a program if discovered late.
Fig.1 An overview of safety pharmacology evaluation for small molecule drug candidates.
Comprehensive Safety Evaluation Portfolio
Creative Biolabs provides an expansive suite of safety pharmacology assessments designed to meet international regulatory expectations while uncovering subtle physiological impacts.
In Vitro Safety Assessment
Small Molecule Cardiac Safety & hERG Evaluation
Creative Biolabs provides small molecule cardiac safety and hERG evaluation, utilizing patch-clamp electrophysiology and fluorescence assays. We quantify ion channel inhibition to predict QT prolongation and ensure regulatory compliance.
Learn More →Small Molecule CNS Safety Monitoring
Creative Biolabs provides a small molecule CNS safety monitoring service, assessing neurobehavioral profiles and seizure liability. We evaluate blood-brain barrier permeability and neurotoxicity to ensure central nervous system safety and de-risk preclinical development.
Learn More →Small Molecule Respiratory Safety Monitoring
Creative Biolabs provides small molecule respiratory safety monitoring, evaluating tidal volume and respiratory rate via plethysmography. We quantify pulmonary function and ventilation mechanics to ensure safety.
Learn More →Connect with Our Scientists – Secure a Detailed Safety Strategy Consultation for Your Lead Candidate
Workflow
To ensure the highest data integrity and regulatory readiness, Creative Biolabs follows a rigorous, phased workflow. This systematic approach allows for real-time data analysis and the flexibility to pivot or expand studies based on emerging safety signals.
Why Choose Us?
Creative Biolabs stands at the forefront of safety pharmacology by integrating deep expertise on rare adverse events and historical safety signals into our highly predictive models. Our unique advantage lies in our specialized ability to translate high-risk innovation into industry-ready assets through rigorous, industrial-grade validation and methodologies. By combining state-of-the-art telemetry instrumentation with high-throughput patch-clamp technology, we provide the translational power necessary to ensure preclinical findings accurately predict human risk. Our multidisciplinary team of toxicologists and pharmacologists works collaboratively to identify off-target liabilities early, significantly reducing the likelihood of late-stage development failure.
Experience the Creative Biolabs Advantage – Partner with Experts to De-risk Your Pipeline
FAQs
How does Creative Biolabs handle 'borderline' hERG signals?
We offer manual patch-clamp follow-ups and computational modeling to differentiate between benign binding and true pro-arrhythmic risk, providing you with a more nuanced risk assessment than a simple IC50 value.
Can you accommodate non-standard animal models for specific targets?
Yes, we provide bespoke study designs across multiple species, including non-human primates (NHP), for molecules with high target specificity that require absolute translational accuracy.
What is the difference between your safety pharmacology and general toxicology services?
While toxicology focuses on structural damage, our safety pharmacology assesses functional changes in vital systems, often in conscious, moving animals via advanced telemetry.
Customer Review
-
Predictive Accuracy
Using Creative Biolabs' safety pharmacology in our research has significantly facilitated the identification of off-target ion channel liabilities that our internal high-throughput screening missed. Their manual patch-clamp validation was the deciding factor for our lead selection. - Michael K*n -
Modality Expertise
Transitioning from traditional small molecules to antisense oligonucleotides was daunting. Creative Biolabs helped us navigate hybridization-independent toxicities using their specialized pro-inflammatory profiling, saving our program from a potential regulatory hold. - Prof. Linda W*er
Related Services
Genotoxicity Assessment Services
Creative Biolabs provides comprehensive genotoxicity assessments, integrating Ames tests and micronucleus assays with advanced DNA damage response (DDR) analysis. We quantify DNA breaks and chromosomal alterations to ensure regulatory compliance.
Learn More →General Toxicology Service
Creative Biolabs provides comprehensive toxicology services, quantifying acute, subchronic, and chronic toxicity. We evaluate infusion safety and predictive toxicology to define safety margins and ensure preclinical-to-clinical success.
Learn More →How to Contact Creative Biolabs
Creative Biolabs provides a high-end, integrated safety pharmacology platform that bridges the gap between innovative discovery and regulatory approval. By combining historical insights, advanced telemetry, and a deep understanding of the physiologic-toxicologic interplay, we ensure your small molecule or hybrid modality reaches its next development milestone with a robust and defensible safety profile.
Contact Our Team for More Information and to Discuss Your Project – Start Your Safety Evaluation Today
Download our brochureLoading case studies...
Online Inquiry